当前位置:首页 - 行情中心 - 回盛生物(300871) - 财务分析

回盛生物

(300871)

  

流通市值:40.66亿  总市值:40.66亿
流通股本:1.84亿   总股本:1.84亿

回盛生物(300871)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.45亿元,每股收益0.27元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益158502.85万元,未分配利润32173.10万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产304614.98万元,负债146112.12万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入399,068,578.251,200,327,933.81792,553,431.27436,303,723.6
营业总成本358,778,707.571,229,801,069.41838,141,263.93468,045,931.31
营业利润50,869,008.58-29,085,123.15-61,134,868.34-64,634,130.29
利润总额50,681,198.76-28,973,419.48-61,203,620.59-64,686,101.19
净利润44,777,497.12-19,773,164.88-47,615,990.17-51,879,057.19
其他综合收益---767,307.88-1,587,603.84
综合收益总额44,777,497.12-19,773,164.88-48,383,298.05-53,466,661.03
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计1,346,009,223.511,312,585,417.221,209,306,834.791,235,017,572.57
非流动资产合计1,700,140,552.571,702,097,447.81,703,226,484.151,706,052,986.59
资产总计3,046,149,776.083,014,682,865.022,912,533,318.942,941,070,559.16
流动负债合计948,094,016.86923,315,102.83893,126,072.47781,533,939.4
非流动负债合计513,027,212.71626,164,645.33595,992,781.03729,500,296.76
负债合计1,461,121,229.571,549,479,748.161,489,118,853.51,511,034,236.16
归属于母公司股东权益合计1,578,253,746.331,457,576,824.021,422,687,148.581,429,736,698.96
股东权益合计1,585,028,546.511,465,203,116.861,423,414,465.441,430,036,323
负债和股东权益合计3,046,149,776.083,014,682,865.022,912,533,318.942,941,070,559.16
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计332,255,252.141,027,042,785.78727,679,278.47450,971,927.45
经营活动现金流出小计274,294,987.98983,510,938.97720,568,634.84481,981,027.82
经营活动产生的现金流量净额57,960,264.1643,531,846.817,110,643.63-31,009,100.37
投资活动现金流入小计96,164,407.02668,897,903.94533,096,404.27325,880,251.36
投资活动现金流出小计223,629,940.01770,712,692.07659,840,673.74387,391,688.3
投资活动产生的现金流量净额-127,465,532.99-101,814,788.13-126,744,269.47-61,511,436.94
筹资活动现金流入小计124,116,220556,087,472423,425,243344,046,379
筹资活动现金流出小计87,759,468.86542,111,104.34393,775,661206,283,860.72
筹资活动产生的现金流量净额36,356,751.1413,976,367.6629,649,582137,762,518.28
汇率变动对现金及现金等价物的影响404,235.28-613,772.49-178,476.97-313,967.68
现金及现金等价物净增加额-32,744,282.41-44,920,346.15-90,162,520.8144,928,013.29
期末现金及现金等价物余额151,847,660.83184,591,943.24139,349,768.58274,440,302.68
最新报告期:2025-05-03
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
国信证券李瑞楠,江海航,鲁家瑞0.891.131.292025-05-03
国信证券李瑞楠,江海航,鲁家瑞0.891.13--2025-03-26
申万宏源朱珺逸------2025-03-26
西南证券徐卿-0.120.931.162025-03-19
TOP↑